By: Kevin Beckman
After a year of scrutiny and several harsh internal and external reports, drug trials by the University of Minnesota’s Department of Psychiatry are one step away from state oversight.
A bill that would require the state’s Ombudsman for Mental Health and Developmental Disabilities to monitor the department’s drug studies was passed by the Minnesota Legislature late last month and now awaits Gov. Mark Dayton’s signature or veto.